Binding and activation properties of human factor XII, prekallikrein, and derived peptides with acidic lipid vesicles.
暂无分享,去创建一个
[1] E. L. Kean. Rapid, sensitive spectrophotometric method for quantitative determination of sulfatides. , 1968, Journal of lipid research.
[2] V. Bloomfield,et al. Quasi-elastic laser light scattering. , 1978, Methods in enzymology.
[3] L. Stryer,et al. Fluorescent probes of biological membranes. , 1970, Proceedings of the National Academy of Sciences of the United States of America.
[4] J. Griffin,et al. Sulfatide-dependent autoactivation of human blood coagulation Factor XII (Hageman Factor). , 1983, The Journal of biological chemistry.
[5] M. Silverberg,et al. Activation of the classical pathway of complement by Hageman factor fragment , 1981, The Journal of experimental medicine.
[6] R. Waldmann,et al. Fitzgerald Trait DEFICIENCY OF A HITHERTO UNRECOGNIZED AGENT , FITZGERALD FACTOR , PARTICIPATING IN SURFACE-MEDIATED REACTIONS OF CLOTTING , FIBRINOLYSIS , GENERATION OF KININS , AND THE PROPERTY OF DILUTED PLASMA ENHANCING VASCULAR PERMEABILITY ( PF / DIL ) , 2022 .
[7] K. Wuepper. PREKALLIKREIN DEFICIENCY IN MAN , 1973, The Journal of experimental medicine.
[8] Kaplan Ap,et al. A pre-albumin activator of prekallikrein. , 1970, Journal of immunology.
[9] P. Lee,et al. Partial purification and characterization of contact activation cofactor. , 1975, The Journal of clinical investigation.
[10] R. Colman,et al. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. , 1977, The Journal of clinical investigation.
[11] K. Fujikawa,et al. Mechanism of activation of bovine factor XI by factor XII and factor XIIa. , 1980, Biochemistry.
[12] V. Bloomfield,et al. Kinetic and mechanistic analysis of prothrombin-membrane binding by stopped-flow light scattering. , 1982, Biochemistry.
[13] K. Wuepper,et al. Flaujeac trait. Deficiency of human plasma kininogen. , 1975, The Journal of clinical investigation.
[14] J. Griffin,et al. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[15] P. Stoffyn. The structure and chemistry of sulfatides , 1966, Journal of the American Oil Chemists' Society.
[16] J. Griffin,et al. Recent Advances in The Understanding of Contact Activation Reactions , 2008, Seminars in thrombosis and hemostasis.
[17] D. Larsson,et al. Molecular arrangements in glycosphingolipids. , 1972, Chemistry and physics of lipids.
[18] K. Karlsson,et al. The identification of sulphatides in human erythrocyte membrane and their relation to sodium-potassium dependent adenosine triphosphatase. , 1978, Journal of biochemistry.
[19] P. E. Bock,et al. Activation of intrinsic blood coagulation by ellagic acid: insoluble ellagic acid-metal ion complexes are the activating species. , 1981, Biochemistry.
[20] M. Pusey,et al. Kinetic and hydrodynamic analysis of blood clotting factor V-membrane binding. , 1982, Biochemistry.
[21] J. Griffin,et al. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen. , 1977, The Journal of clinical investigation.
[22] P. S. Chen,et al. Microdetermination of Phosphorus , 1956 .
[23] K. Fujikawa,et al. Activation of bovine factor XII (Hageman factor) by plasma kallikrein. , 1980, Biochemistry.
[24] K. Fujikawa,et al. Activation of bovine factor VII (proconvertin) by factor XIIa (activated Hageman factor). , 1977, Biochemistry.
[25] Ching-Hsien Huang,et al. Phosphatidylcholine vesicles. Formation and physical characteristics , 1969 .
[26] C. Kluft. Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein. , 1978, The Journal of laboratory and clinical medicine.
[27] J. Dunn,et al. Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate. , 1980, The Journal of biological chemistry.
[28] J. Griffin. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII). , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[29] W. Hathaway,et al. Evidence for a new plasma thromboplastin factor. I. Case report, coagulation studies and physicochemical properties. , 1965, Blood.
[30] J. Margolis. THE INTERRELATIONSHIP OF COAGULATION OF PLASMA AND RELEASE OF PEPTIDES , 1963, Annals of the New York Academy of Sciences.
[31] O. Ratnoff,et al. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. , 1961, The Journal of clinical investigation.
[32] O. Ratnoff,et al. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. , 1955, The Journal of clinical investigation.
[33] R. Colman,et al. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. , 1975, The Journal of clinical investigation.
[34] J. Dunn,et al. The cleavage and formation of activated human Hageman factor by autodigestion and by kallikrein. , 1982, The Journal of biological chemistry.
[35] R. Rosenthal,et al. New Hemophilia-like Disease Caused by Deficiency of a Third Plasma Thromboplastin Factor.∗ , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[36] A. Bangham,et al. Membrane models with phospholipids. , 1968, Progress in biophysics and molecular biology.